2023 Q3 Form 10-Q Financial Statement
#000177912823000077 Filed on August 09, 2023
Income Statement
| Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
|---|---|---|---|
| Revenue | $71.44M | $60.99M | $35.63M |
| YoY Change | 56.25% | 71.16% | 175.14% |
| Cost Of Revenue | $55.86M | $50.62M | $30.52M |
| YoY Change | 53.23% | 65.85% | 205.95% |
| Gross Profit | $15.58M | $10.37M | $5.111M |
| YoY Change | 68.13% | 102.88% | 71.8% |
| Gross Profit Margin | 21.81% | 17.0% | 14.34% |
| Selling, General & Admin | $21.95M | $21.14M | $13.78M |
| YoY Change | 24.24% | 53.37% | 1644.56% |
| % of Gross Profit | 140.9% | 203.86% | 269.65% |
| Research & Development | $1.076M | $1.440M | $1.062M |
| YoY Change | -46.89% | 35.59% | 228.79% |
| % of Gross Profit | 6.91% | 13.89% | 20.78% |
| Depreciation & Amortization | $1.850M | $1.810M | $1.155M |
| YoY Change | 28.38% | 56.71% | 185.19% |
| % of Gross Profit | 11.87% | 17.46% | 22.6% |
| Operating Expenses | -$8.164M | -$7.875M | $14.84M |
| YoY Change | -141.45% | -153.05% | -28.37% |
| Operating Profit | -$7.448M | -$12.21M | -$9.733M |
| YoY Change | -28.58% | 25.44% | 25.25% |
| Interest Expense | $2.150M | -$399.0K | $18.15M |
| YoY Change | 73.53% | -102.2% | -222.83% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $7.866M | -$399.0K | $18.15M |
| YoY Change | 534.87% | -102.2% | -209.87% |
| Pretax Income | $418.0K | -$12.61M | $8.412M |
| YoY Change | -104.55% | -249.88% | -134.64% |
| Income Tax | $129.0K | -$376.0K | $0.00 |
| % Of Pretax Income | 30.86% | 0.0% | |
| Net Earnings | $289.0K | -$12.23M | $8.412M |
| YoY Change | -103.13% | -245.41% | -134.64% |
| Net Earnings / Revenue | 0.4% | -20.06% | 23.61% |
| Basic Earnings Per Share | $0.00 | -$0.17 | $0.11 |
| Diluted Earnings Per Share | $0.00 | -$0.17 | $0.10 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 74.11M shares | 73.17M shares | 71.05M shares |
| Diluted Shares Outstanding | 81.01M shares | 73.17M shares | 78.50M shares |
Balance Sheet
| Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $173.2M | $169.7M | $256.2M |
| YoY Change | -14.34% | -33.76% | -23.11% |
| Cash & Equivalents | $36.82M | $37.35M | $186.6M |
| Short-Term Investments | $136.4M | $132.3M | $69.61M |
| Other Short-Term Assets | $14.50M | $16.76M | $12.39M |
| YoY Change | 21.73% | 35.23% | 55.01% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $21.04M | $22.53M | $9.672M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $208.7M | $209.0M | $278.2M |
| YoY Change | -7.4% | -24.89% | -18.82% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $3.322M | $2.909M | $2.304M |
| YoY Change | 49.64% | 26.26% | 33.57% |
| Goodwill | $39.23M | $39.80M | $13.33M |
| YoY Change | 23.16% | 198.6% | |
| Intangibles | $41.57M | $43.93M | $22.74M |
| YoY Change | -14.34% | 93.17% | 2441.12% |
| Long-Term Investments | $400.0K | $390.0K | $200.0K |
| YoY Change | 2.56% | 95.0% | 0.0% |
| Other Assets | $974.0K | $998.0K | $1.384M |
| YoY Change | -25.76% | -27.89% | 874.65% |
| Total Long-Term Assets | $108.8M | $111.2M | $45.96M |
| YoY Change | 7.43% | 141.97% | 1243.92% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $208.7M | $209.0M | $278.2M |
| Total Long-Term Assets | $108.8M | $111.2M | $45.96M |
| Total Assets | $317.5M | $320.2M | $324.2M |
| YoY Change | -2.8% | -1.24% | -6.34% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $18.80M | $14.88M | $7.648M |
| YoY Change | 62.6% | 94.55% | 54.26% |
| Accrued Expenses | $4.800M | $4.380M | $2.364M |
| YoY Change | 82.72% | 85.28% | 609.91% |
| Deferred Revenue | $6.835M | $10.01M | $8.500M |
| YoY Change | 13.24% | 17.81% | 61.41% |
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $30.36M | $29.27M | $18.51M |
| YoY Change | 50.13% | 58.13% | 75.35% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $22.80M | $28.81M | $13.24M |
| YoY Change | -3.32% | 117.61% | -65.96% |
| Total Long-Term Liabilities | $22.80M | $28.81M | $13.24M |
| YoY Change | -3.32% | 117.61% | -65.96% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $30.36M | $29.27M | $18.51M |
| Total Long-Term Liabilities | $22.80M | $28.81M | $13.24M |
| Total Liabilities | $54.64M | $59.42M | $31.90M |
| YoY Change | 24.31% | 86.29% | -35.5% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$125.8M | -$126.1M | -$79.02M |
| YoY Change | 42.54% | 59.59% | 16.19% |
| Common Stock | $7.000K | $7.000K | $7.000K |
| YoY Change | 0.0% | 0.0% | 0.0% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $262.9M | $260.8M | $292.3M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $317.5M | $320.2M | $324.2M |
| YoY Change | -2.8% | -1.24% | -6.34% |
Cashflow Statement
| Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $289.0K | -$12.23M | $8.412M |
| YoY Change | -103.13% | -245.41% | -134.64% |
| Depreciation, Depletion And Amortization | $1.850M | $1.810M | $1.155M |
| YoY Change | 28.38% | 56.71% | 185.19% |
| Cash From Operating Activities | $2.020M | -$8.197M | -$11.61M |
| YoY Change | -131.81% | -29.4% | 22.66% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $700.0K | $744.0K | -$189.0K |
| YoY Change | -852.69% | -493.65% | -17.83% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$2.340M | $4.518M | $196.8M |
| YoY Change | -98.18% | -97.7% | -164.81% |
| Cash From Investing Activities | -$3.040M | $3.774M | $196.6M |
| YoY Change | -97.64% | -98.08% | -164.7% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | -20.00K | -948.0K |
| YoY Change | -100.0% | -97.89% | -100.29% |
| NET CHANGE | |||
| Cash From Operating Activities | 2.020M | -8.197M | -11.61M |
| Cash From Investing Activities | -3.040M | 3.774M | 196.6M |
| Cash From Financing Activities | 0.000 | -20.00K | -948.0K |
| Net Change In Cash | -1.020M | -4.443M | 184.1M |
| YoY Change | -99.25% | -102.41% | 883.42% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $2.020M | -$8.197M | -$11.61M |
| Capital Expenditures | $700.0K | $744.0K | -$189.0K |
| Free Cash Flow | $1.320M | -$8.941M | -$11.42M |
| YoY Change | -121.09% | -21.71% | 23.67% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
|
http://fasb.org/us-gaap/2023#WarrantsAndRightsOutstanding | ||
| CY2023Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2023Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2023Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
20000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
18000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12232000 | usd |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
260764000 | usd |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
281470000 | usd |
| CY2022Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
58000 | usd |
| CY2022Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
1006000 | usd |
| CY2022Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
1513000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8412000 | usd |
| CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
292291000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
274489000 | usd |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
54000 | usd | |
| us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
101000 | usd | |
| us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
1785000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
943000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-22424000 | usd | |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
260764000 | usd |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
79000 | usd | |
| us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
1011000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
510000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2600000 | usd | |
| CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
292291000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-22424000 | usd | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3462000 | usd | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2300000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6018000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3942000 | usd | |
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
1896000 | usd | |
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-21816000 | usd | |
| us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-95000 | usd | |
| us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-1712000 | usd | |
| us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-5000 | usd | |
| us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
5000 | usd | |
| us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
3024000 | usd | |
| us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
0 | usd | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-572000 | usd | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | usd | |
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | usd | |
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-65000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2625000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
3902000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
11630000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4124000 | usd | |
| us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
24000 | usd | |
| us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
1152000 | usd | |
| blde |
Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
|
-377000 | usd | |
| blde |
Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
|
-106000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
87000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1275000 | usd | |
| us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
3307000 | usd | |
| us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
2524000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-25052000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-21675000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1390000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
626000 | usd | |
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
135000 | usd | |
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
453000 | usd | |
| us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
20532000 | usd | |
| us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
208700000 | usd | |
| us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
130145000 | usd | |
| us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
0 | usd | |
| us-gaap |
Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
131187000 | usd | |
| us-gaap |
Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
0 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
20049000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
207621000 | usd | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
54000 | usd | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
79000 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
101000 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1011000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-47000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-932000 | usd | |
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
20000 | usd | |
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-5030000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
185021000 | usd | |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
44423000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3225000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
39393000 | usd |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
188246000 | usd |
| CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
37348000 | usd |
| CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
186556000 | usd |
| CY2023Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
2045000 | usd |
| CY2022Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
1690000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
39393000 | usd |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
188246000 | usd |
| blde |
Noncash Or Part Noncash Adoption Of Accounting Standards Update
NoncashOrPartNoncashAdoptionOfAccountingStandardsUpdate
|
7312000 | usd | |
| blde |
Noncash Or Part Noncash Adoption Of Accounting Standards Update
NoncashOrPartNoncashAdoptionOfAccountingStandardsUpdate
|
5871000 | usd | |
| us-gaap |
Nature Of Operations
NatureOfOperations
|
Description of Business and Summary of Significant Accounting Policies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blade Air Mobility, Inc. (“Blade” or the “Company”), headquartered in New York, New York, is a technology-powered, global air mobility platform that provides consumers with a cost effective and time efficient alternative to ground transportation for congested routes. Blade’s Passenger reporting segment arranges charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes operating in various locations throughout the United States and abroad. Blade’s Medical reporting segment arranges air medical transportation of human organs in the United States, providing end-to-end logistics for transplant centers and organ procurement organizations utilizing helicopters, jets, turboprops and ground vehicles. Blade’s platform utilizes an asset-light business model, providing transportation to its customers through a network of contracted aircraft operators. Blade does not own or operate aircraft.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Management’s opinion is that all adjustments (consisting of normal accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. These financial statements should be read in conjunction with the Company’s consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Short-Term Investments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held-to-Maturity Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments in held-to-maturity securities consist of investment grade U.S. Treasury obligations with maturity dates of less than 365 days. The Company has the ability and intention to hold these securities until maturity. Accordingly, these securities are recorded in the Company's unaudited interim condensed consolidated balance sheet at amortized cost and interest is recorded within interest income on the Company's unaudited interim condensed consolidated statement of operations. The held-to-maturity securities balance at June 30, 2023 and December 31, 2022 was $132,342 and $130,382, respectively. The market value of the held-to-maturity securities at June 30, 2023 and December 31, 2022 was $132,318 and $130,352, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Short-Term Investments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other short-term investments consist of highly-liquid investments available for sale. As of June 30, 2023, other short-term investments consisted of an available-for-sale, traded, debt securities fund, which is recorded at fair value with unrealized gains and losses reported, net of tax, in “Accumulated other comprehensive income (loss)”, unless unrealized losses are determined to be unrecoverable. Realized gains and losses on the sale of securities are determined by specific identification. The Company considers all available-for-sale securities as available to support current operational liquidity needs and, therefore, classifies all securities as current assets within short-term investments on the Company’s unaudited interim condensed consolidated balance sheets. These other short-term investments are excluded from disclosure under “fair value of financial instruments” due to the net asset value practical expedient. The other short-term investments balance at June 30, 2023 and December 31, 2022 was $— and $20,358, respectively. The cost of other short-term investments at June 30, 2023 and December 31, 2022 was $— and $20,460, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowances for Expected Credit Losses </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accounts receivable consists principally of amounts due from the Company’s MediMobility Organ Transport customers, which are large hospitals that receive terms for payment. The allowance for expected credit losses on receivables is used to present accounts receivable, net at an amount that represents the Company’s estimate of the related transaction price recognized as revenue. The allowance represents an estimate of expected credit losses over the lifetime of the receivables, even if the loss is considered remote, and reflects expected recoveries of amounts previously written-off. We have determined our allowance for expected credit losses based on a specific evaluation of individual receivables and an analysis </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of past default experience for remaining receivables. We have historically not experienced significant losses on our receivables. We generally do not require customers to provide collateral for purchases. During the six months ended June 30, 2023, the Company recorded an allowance for credit losses of $63 for potential uncollectible accounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include, but are not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected to use such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company that is not an emerging growth company or is an emerging growth company that has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the financial statements. Significant estimates and assumptions by management include, but are not limited to, the carrying value of long-lived assets, the fair value of intangible assets and goodwill, contingencies, the determination of whether a contract contains a lease, the allocation of consideration between lease and nonlease components, the determination of incremental borrowing rates for leases and the provision for income taxes and related deferred tax accounts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards - Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2023, we adopted ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Contract Assets and Contract Liabilities From Contracts With Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASU 2021-08, that requires acquiring companies to apply ASC 606 to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination consistent with those recorded by the acquiring company. The Company does not have significant contracts with customers requiring </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance beyond delivery. To the extent we acquire additional companies in our existing lines of business, the adoption of this standard will not have a material impact on our results of operations or financial position.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU changes accounting for credit losses on loans receivable and debt securities from an incurred loss methodology to an expected credit loss methodology. Among other things, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Accordingly, ASU 2016-13 requires the use of forward-looking information to form credit loss estimates. In addition, ASU 2016-13 amends the accounting for credit losses on debt securities and purchased financial assets with credit deterioration. The Company adopted ASU 2016-13 as of January 1, 2023. The company’s financial assets that are subject to the new standard are predominantly accounts receivable and short-term investments classified as held-to-maturities (e.g., U.S. Treasury obligations). The Company’s receivables consist principally of MediMobility Organ Transport customers, which are large hospitals that receive terms of 45 days or less. U.S. Treasury obligations are rated as investment grade with maturities of less than 365 days. Given our historical experience, the short duration lifetime of these financial assets and the short time horizon over which to consider expectations of future economic conditions, the company assessed that non-collection of the cost basis of these financial assets is remote. The adoption of ASU 2016-13 did not materially impact the Company’s unaudited interim condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements - Not Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The objective of this update is to simplify the accounting for convertible preferred stock by removing the existing guidance in ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt: Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (“ASC 470-20”), that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. This amendment also further revises the guidance in ASU 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. The amendments in ASU 2020-06 are effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect the adoption of ASU 2020-06 to have a significant impact on its consolidated financial statements.</span></div> | ||
| CY2023Q2 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
132342000 | usd |
| CY2022Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
130382000 | usd |
| CY2023Q2 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
132318000 | usd |
| CY2022Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
130352000 | usd |
| CY2023Q2 | us-gaap |
Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
|
0 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Trading And Available For Sale
DebtSecuritiesTradingAndAvailableForSale
|
20358000 | usd |
| CY2023Q2 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
0 | usd |
| CY2022Q4 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
20460000 | usd |
| CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
63000 | usd |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the financial statements. Significant estimates and assumptions by management include, but are not limited to, the carrying value of long-lived assets, the fair value of intangible assets and goodwill, contingencies, the determination of whether a contract contains a lease, the allocation of consideration between lease and nonlease components, the determination of incremental borrowing rates for leases and the provision for income taxes and related deferred tax accounts.</span></div> | ||
| CY2023Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
10014000 | usd |
| CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
6709000 | usd |
| blde |
Contract With Customer Liability Customer Credit Period
ContractWithCustomerLiabilityCustomerCreditPeriod
|
P1Y | ||
| CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
6709000 | usd |
| CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
5976000 | usd |
| blde |
Contract With Customer Liability Increase For Current Activity
ContractWithCustomerLiabilityIncreaseForCurrentActivity
|
34830000 | usd | |
| blde |
Contract With Customer Liability Increase For Current Activity
ContractWithCustomerLiabilityIncreaseForCurrentActivity
|
36662000 | usd | |
| blde |
Contract With Customer Liability Revenue Deferred And Recognized During Period
ContractWithCustomerLiabilityRevenueDeferredAndRecognizedDuringPeriod
|
31525000 | usd | |
| blde |
Contract With Customer Liability Revenue Deferred And Recognized During Period
ContractWithCustomerLiabilityRevenueDeferredAndRecognizedDuringPeriod
|
34138000 | usd | |
| CY2023Q2 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
10014000 | usd |
| CY2022Q2 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
8500000 | usd |
| us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
3405000 | usd | |
| us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
3603000 | usd | |
| CY2023Q2 | blde |
Number Of Business Lines
NumberOfBusinessLines
|
3 | lineofbusiness |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment | |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
60989000 | usd |
| CY2022Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
35633000 | usd |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
106260000 | usd | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
62263000 | usd | |
| CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
23186000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
17692000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4380000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3362000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
19833000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
14970000 | usd |
| CY2023Q2 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
126000 | usd |
| CY2022Q2 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
59000 | usd |
| us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
220000 | usd | |
| us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
220000 | usd | |
| us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
97000 | usd | |
| CY2023Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
494000 | usd |
| CY2022Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
227000 | usd |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
961000 | usd | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
961000 | usd | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
410000 | usd | |
| CY2023Q2 | blde |
Operating Lease Cost Of Revenues
OperatingLeaseCostOfRevenues
|
1150000 | usd |
| CY2022Q2 | blde |
Operating Lease Cost Of Revenues
OperatingLeaseCostOfRevenues
|
250000 | usd |
| blde |
Operating Lease Cost Of Revenues
OperatingLeaseCostOfRevenues
|
2140000 | usd | |
| blde |
Operating Lease Cost Of Revenues
OperatingLeaseCostOfRevenues
|
2140000 | usd | |
| blde |
Operating Lease Cost Of Revenues
OperatingLeaseCostOfRevenues
|
250000 | usd | |
| CY2023Q2 | us-gaap |
Lease Cost
LeaseCost
|
1770000 | usd |
| CY2022Q2 | us-gaap |
Lease Cost
LeaseCost
|
536000 | usd |
| us-gaap |
Lease Cost
LeaseCost
|
3321000 | usd | |
| us-gaap |
Lease Cost
LeaseCost
|
757000 | usd | |
| CY2023Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0910 | |
| CY2023Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P6Y8M12D | |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
3275000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
6189000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
5030000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
3997000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
3857000 | usd |
| CY2023Q2 | blde |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
10597000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
32945000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
8732000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
24213000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2797000 | usd |
| CY2022Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1844000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5679000 | usd | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3942000 | usd | |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment | |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment | |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
60989000 | usd |
| CY2022Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
35633000 | usd |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
106260000 | usd | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
62263000 | usd | |
| CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
10369000 | usd |
| CY2022Q2 | us-gaap |
Gross Profit
GrossProfit
|
5111000 | usd |
| us-gaap |
Gross Profit
GrossProfit
|
17533000 | usd | |
| us-gaap |
Gross Profit
GrossProfit
|
8034000 | usd | |
| CY2023Q2 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
22578000 | usd |
| CY2022Q2 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
14844000 | usd |
| us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
42569000 | usd | |
| us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
31457000 | usd | |
| CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12209000 | usd |
| CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9733000 | usd |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-25036000 | usd | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23423000 | usd | |
| CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
-7875000 | usd |
| CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
-8101000 | usd |
| us-gaap |
Operating Expenses
OperatingExpenses
|
-17221000 | usd | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
-16797000 | usd | |
| CY2023Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-399000 | usd |
| CY2022Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
18145000 | usd |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2040000 | usd | |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
20823000 | usd | |
| CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-12608000 | usd |
| CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
8412000 | usd |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-22996000 | usd | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2600000 | usd | |
| CY2023Q2 | blde |
Gross Profit Margin
GrossProfitMargin
|
0.170 | |
| CY2022Q2 | blde |
Gross Profit Margin
GrossProfitMargin
|
0.143 | |
| blde |
Gross Profit Margin
GrossProfitMargin
|
0.165 | ||
| blde |
Gross Profit Margin
GrossProfitMargin
|
0.129 | ||
| CY2023Q2 | us-gaap |
Goodwill
Goodwill
|
39797000 | usd |
| CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
39445000 | usd |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
60989000 | usd |
| CY2022Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
35633000 | usd |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
106260000 | usd | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
62263000 | usd | |
| CY2023Q2 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
26095000 | usd |
| CY2022Q2 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
19729000 | usd |
| CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-376000 | usd |
| CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-572000 | usd | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd | |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12232000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8412000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-22424000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2600000 | usd | |
| CY2023Q2 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
0 | usd |
| CY2022Q2 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
256000 | usd |
| us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
0 | usd | |
| us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
0 | usd | |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-12232000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
8156000 | usd |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-22424000 | usd | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2600000 | usd | |
| CY2023Q2 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
|
0 | usd |
| CY2022Q2 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
|
-256000 | usd |
| us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
|
0 | usd | |
| us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
|
0 | usd | |
| CY2023Q2 | blde |
Undistributed Earnings Loss Reallocated To Participating Securities Diluted
UndistributedEarningsLossReallocatedToParticipatingSecuritiesDiluted
|
0 | usd |
| CY2022Q2 | blde |
Undistributed Earnings Loss Reallocated To Participating Securities Diluted
UndistributedEarningsLossReallocatedToParticipatingSecuritiesDiluted
|
-233000 | usd |
| blde |
Undistributed Earnings Loss Reallocated To Participating Securities Diluted
UndistributedEarningsLossReallocatedToParticipatingSecuritiesDiluted
|
0 | usd | |
| blde |
Undistributed Earnings Loss Reallocated To Participating Securities Diluted
UndistributedEarningsLossReallocatedToParticipatingSecuritiesDiluted
|
0 | usd | |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-12232000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
8179000 | usd |
| us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-22424000 | usd | |
| us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2600000 | usd | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
73169003 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
71051523 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
72584138 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
70913597 | shares | |
| CY2023Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
| CY2022Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
7445833 | shares |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares | |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares | |
| CY2023Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
7445833 | shares |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares | |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
73169003 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
78497356 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
72584138 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
70913597 | shares | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
| CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.11 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.31 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | ||
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
| CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.10 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.31 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | ||
| CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
28250387 | shares |
| CY2022Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15218193 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
28250387 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
24165406 | shares | |
| blde |
Unrecorded Unconditional Purchase Obligation Minimum Period Guaranteed As Of Termination Date
UnrecordedUnconditionalPurchaseObligationMinimumPeriodGuaranteedAsOfTerminationDate
|
P1Y | ||
| blde |
Class Of Warrant Or Right Redemption Commencement Period
ClassOfWarrantOrRightRedemptionCommencementPeriod
|
P90D | ||
| blde |
Class Of Warrant Or Right Notice Of Redemption Period
ClassOfWarrantOrRightNoticeOfRedemptionPeriod
|
P30D | ||
| CY2022Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
7083000 | usd |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
1896000 | usd | |
| CY2023Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
8979000 | usd |
